{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["7"],"submitter":["Lanzillotta M"],"pubmed_abstract":["<b>Introduction:</b> Treatment of autoimmune pancreatitis (AIP) is based solely on consensus and has yet to become standardized. Consequently, therapeutic regimens vary greatly between countries and centers, and largely depend on the experience of the physician. At this moment, the optimal regimen for inducing disease remission and preventing relapse is unknown. <b>Objectives:</b> The primary objective of this study is to describe current treatment regimens used in Europe, and to compare their effectiveness in inducing remission and preventing and treating relapse. The secondary objectives are: to identify risk factors for relapse; to assess the diagnostic accuracy of the Unified-AIP criteria; to assess the performance of the M-ANNHEIM score for predicting relapse; and to assess long-term "],"journal":["Frontiers in medicine"],"pagination":["408"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7419461"],"repository":["biostudies-literature"],"pubmed_title":["PrescrAIP: A Pan-European Study on Current Treatment Regimens of Auto-Immune Pancreatitis."],"pmcid":["PMC7419461"],"pubmed_authors":["Poulsen JL","Macinga P","Overbeek KA","Demirci AF","Lohr M","Lanzillotta M","Vinge-Holmquist O","Rosendahl J"],"additional_accession":[]},"is_claimable":false,"name":"PrescrAIP: A Pan-European Study on Current Treatment Regimens of Auto-Immune Pancreatitis.","description":"<b>Introduction:</b> Treatment of autoimmune pancreatitis (AIP) is based solely on consensus and has yet to become standardized. Consequently, therapeutic regimens vary greatly between countries and centers, and largely depend on the experience of the physician. At this moment, the optimal regimen for inducing disease remission and preventing relapse is unknown. <b>Objectives:</b> The primary objective of this study is to describe current treatment regimens used in Europe, and to compare their effectiveness in inducing remission and preventing and treating relapse. The secondary objectives are: to identify risk factors for relapse; to assess the diagnostic accuracy of the Unified-AIP criteria; to assess the performance of the M-ANNHEIM score for predicting relapse; and to assess long-term ","dates":{"release":"2020-01-01T00:00:00Z","publication":"2020","modification":"2025-05-18T13:21:12.412Z","creation":"2025-05-18T13:21:12.412Z"},"accession":"S-EPMC7419461","cross_references":{"pubmed":["32850908"],"doi":["10.3389/fmed.2020.00408"]}}